Make Blood Cancer Visible

September marks Blood Cancer Awareness Month. There are over 140 different types of blood cancers, and many forms are rare, life threatening conditions, often orphan diseases with few patients.1 However, together blood cancers – like leukaemias, lymphomas and myelomas – make up seven percent of all cancers.2,3 Every year, over 900,000 people are diagnosed with blood cancer worldwide,3 however many people remain unaware of these serious, often incurable diseases, leaving blood cancer with very little public visibility. This limited visibility can lead to challenges for patients..

More News

World Hepatitis Day

28 July marks World Hepatitis Day. World Hepatitis Day is coordinated by the World Hepatitis Alliance, of which Janssen is a supporter, and recognised by both the World Health Organization and the United Nations. This day serves as an opportunity..

2014 Report Johnson & Johnson Corporate Citizenship Trust

The 2014 Trust Annual Report -‘A Year of Making it Happen’- has now been published, showcasing the work that the Trust and Johnson & Johnson Companies, including Janssen, are making to deliver a long-term, sustainable impact to human health. The..

Bert Vogelstein, M.D., Wins 2015 Dr. Paul Janssen Award

June 17, 2015 –Dr. Bert Vogelstein of Johns Hopkins University, Johns Hopkins Kimmel Cancer Center and the Howard Hughes Medical Institute is the winner of the 2015 Dr. Paul Janssen Award for Biomedical Research for his breakthroughs in oncology research,..

Young Europeans want healthcare policy to cross borders

Brussels, 16 June 2015 – Greater EU involvement and more Member State cooperation in healthcare is called for in a book of future-proof recommendations launched today by the European Health Parliament, the pan-European platform of 80 young healthcare experts. At an..

THE DISEASE LENS
Explore and compare disease data across 31 European countries

extraordinary efforts

a race against time

the world is our lab

transforming the study

we make hope

Quote of the Month - Magdalena Kalata, President of the European Health Parliament.

 

 

From-Molecule-to-Medicine